2025.02.25本文字数:995,阅读时长大约3分钟导读:HOOKIPA Pharma因研发管线受挫、罗氏终止合作及投资机构信心不足,曾计划收购Poolbeg Pharma以拓展业务,但近期因资金状况改善而终止收购。此前,双方曾就股权分配及融资计划展开讨论,吉利德还参与了3000万美元的私募融资。然而,鉴于CAR-T市场增长放缓及Poolbeg核心产品POLB 001市场前景存疑,收购的必要性...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.